Cartesian Therapeutics, Inc.
RNAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001453687
No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Cartesian Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 64
- +3 vs. Q2 2024
- Shares held
- 6.87M
- +4.00M (+139.8%) vs. Q2 2024
- Total value
- $110.3M
- +$33.1M (+42.8%) vs. Q2 2024
- New holders
- 16
- 20 more added
- Sold out
- 13
- 10 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNAC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 94 | $90.4M |
| Q1 2026 | 83 | $43.9M |
| Q4 2025 | 67 | $37.2M |
| Q3 2025 | 68 | $60.9M |
| Q2 2025 | 66 | $66.5M |
| Q1 2025 | 72 | $86.7M |
| Q4 2024 | 68 | $119.5M |
| Q3 2024 | 64 | $110.3M |
| Q2 2024 | 62 | $88.3M |
| Q1 2024 | 70 | $35.3M |
| Q4 2023 | 80 | $37.8M |
| Q3 2023 | 87 | $57.2M |
| Q2 2023 | 92 | $63.2M |
| Q1 2023 | 95 | $65.1M |
| Q4 2022 | 86 | $62.8M |
| Q3 2022 | 97 | $104.9M |
| Q2 2022 | 93 | $79.3M |
| Q1 2022 | 102 | $71.6M |
| Q4 2021 | 106 | $185.7M |
| Q3 2021 | 103 | $216.7M |
| Q2 2021 | 101 | $219.2M |
| Q1 2021 | 98 | $245.1M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Cartesian Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hazlett, Burt & Watson, Inc. | 12 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 16 | $0 | 0.00% | +12+300.0% | Added |
| CoreCap Advisors, LLC | 1 | $0 | 0.00% | +1 | New |
| Parallel Advisors, LLC | 3 | $48 | 0.00% | 00.0% | Unchanged |
| Sterling Capital Management LLC | 7 | $113 | 0.00% | +7 | New |
| Nisa Investment Advisors, LLC | 11 | $177 | 0.00% | −3−21.4% | Reduced |
| SRS Capital Advisors, Inc. | 12 | $194 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 18 | $290 | 0.00% | 00.0% | Unchanged |
| WR Wealth Planners, LLC | 39 | $629 | 0.00% | 00.0% | Unchanged |
| Mirae Asset Global Investments Co., Ltd. | 3,715 | $669 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 66 | $1.06K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 130 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 234 | $3.77K | 0.00% | −62−20.9% | Reduced |
| California State Teachers Retirement System | 524 | $8.45K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 567 | $9.14K | 0.00% | −1,198−67.9% | Reduced |
| Ameritas Investment Partners, Inc. | 708 | $11.4K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 801 | $12.9K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 1,651 | $26.6K | 0.00% | +909+122.5% | Added |
| Hall Laurie J Trustee | 1,759 | $28.0K | 0.01% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 1,761 | $28.0K | 0.00% | +1,761 | New |
| Wells Fargo & Company | 2,279 | $36.7K | 0.00% | −88−3.7% | Reduced |
| Royal Bank of Canada | 2,938 | $47.0K | 0.00% | +125+4.4% | Added |
| Deutsche Bank AG | 3,638 | $58.6K | 0.00% | 00.0% | Unchanged |
| Corebridge Financial, Inc. | 3,864 | $62.3K | 0.00% | −24−0.6% | Reduced |
| Mirae Asset Global ETFs Holdings Ltd. | 3,997 | $64.4K | 0.00% | +2,370+145.7% | Added |
| Johnson Financial Group, Inc. | 4,618 | $74.4K | 0.00% | +4,618 | New |
| New York State Common Retirement Fund | 5,102 | $82.2K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 5,217 | $84.1K | 0.00% | +3,645+231.9% | Added |
| UBS Group AG | 5,339 | $86.1K | 0.00% | +3,102+138.7% | Added |
| Bank of America Corp | 7,570 | $122.0K | 0.00% | +2,314+44.0% | Added |
| Rhumbline Advisers | 9,274 | $149.5K | 0.00% | +787+9.3% | Added |
| Bridgeway Capital Management, LLC | 10,193 | $164.3K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 10,393 | $167.5K | 0.00% | +10,393 | New |
| Goldman Sachs Group Inc | 11,336 | $182.7K | 0.00% | +11,336 | New |
| Barclays PLC | 11,611 | $187.2K | 0.00% | +7,849+208.6% | Added |
| Twin Focus Capital Partners, LLC | 12,000 | $193.4K | 0.03% | +2,000+20.0% | Added |
| Two Sigma Investments, LP | 12,911 | $208.1K | 0.00% | +12,911 | New |
| Boothbay Fund Management, LLC | 14,518 | $234.0K | 0.01% | −54,022−78.8% | Reduced |
| Ironwood Investment Management LLC | 14,631 | $235.9K | 0.11% | +14,631 | New |
| Bank of New York Mellon Corp | 15,102 | $243.4K | 0.00% | −4,814−24.2% | Reduced |
| Lake Street Advisors Group, LLC | 15,822 | $255.1K | 0.01% | −15,822−50.0% | Reduced |
| Charles Schwab Investment Management Inc | 19,048 | $307.1K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 22,011 | $354.8K | 0.00% | +14,764+203.7% | Added |
| Delphi Financial Group, Inc. | 22,028 | $355.1K | 0.20% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 24,210 | $390.3K | 0.00% | −10,540−30.3% | Reduced |
| Freestone Capital Holdings, LLC | 25,921 | $417.8K | 0.01% | +17,921+224.0% | Added |
| Balyasny Asset Management LLC | 49,497 | $797.9K | 0.00% | +49,497 | New |
| Schonfeld Strategic Advisors LLC | 50,000 | $797.9K | 0.01% | +50,000 | New |
| Ikarian Capital, LLC | 52,193 | $841.4K | 0.26% | −190,177−78.5% | Reduced |
| Northern Trust Corp | 63,115 | $1.02M | 0.00% | +32,191+104.1% | Added |
| 683 Capital Management, LLC | 75,431 | $1.22M | 0.12% | +75,431 | New |
| Armistice Capital, LLC | 98,565 | $1.59M | 0.04% | +98,565 | New |
| Yale University | 100,000 | $1.61M | 66.30% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 135,700 | $2.19M | 0.00% | +2,737+2.1% | Added |
| State Street Corp | 157,495 | $2.54M | 0.00% | +3,830+2.5% | Added |
| Erste Asset Management GmbH | 173,566 | $2.80M | 0.03% | +51,333+42.0% | Added |
| Great Point Partners LLC | 200,000 | $3.22M | 0.97% | +200,000 | New |
| Vanguard Group Inc | 243,089 | $3.92M | 0.00% | +6,432+2.7% | Added |
| JPMorgan Chase & Co | 309,018 | $4.98M | 0.00% | +2,688+0.9% | Added |
| Citadel Advisors LLC | 375,767 | $5.76M | 0.01% | +375,767 | New |
| BlackRock, Inc. | 423,466 | $6.83M | 0.00% | +423,466 | New |
| Siren, L.L.C. | 572,236 | $9.22M | 0.46% | +572,236 | New |
| MPM Oncology Impact Management LP | 629,423 | $10.1M | 1.52% | +369,727+142.4% | Added |
| FMR LLC | 2,851,830 | $46.0M | 0.00% | +2,341,054+458.3% | Added |
| Artal Group S.A. | 0 | $0 | 0.00% | −304,554−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −90,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −30,038−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −25,070−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −17,052−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −13,010−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −2,838−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −1,824−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −1,725−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −152−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |